Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology

Keyphrases

• Nanomedicine 100%
• Cancer Biology 100%
• Nanoparticle Technology 100%
• Cancer Nanotechnology 100%
• Active Targeting 100%
• Passive Targeting 100%
• Pharmaceutical Companies 50%
• Tumor 50%
• Lessons Learned 50%
• Nanotechnology 50%
• Targeted Nanoparticles 50%
• Tolerability 50%
• Personalized Medicine 50%
• Clinical Outcomes 50%
• Nanoparticle Binding 50%
• Exponential Growth 50%
• Cancer Treatment 50%
• Cancer Therapy 50%
• Significant Risk Factors 50%
• Tumor-associated Macrophages 50%
• Oncology 50%
• Abraxane 50%
• Permeability Effect 50%
• Preferential Retention 50%
• Doxil 50%
• Tumoral 50%
• Enhanced Permeability 50%
• Therapeutic Nanoparticles 50%
• Cancer Nanotherapeutics 50%
• Retention Effect 50%
• Oncology Drugs 50%
• New Drug Candidate 50%
• Oncology Drug Development 50%
• Enhanced Retention 50%
• MM-398 50%
• Differentiated Products 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Malignant Neoplasm 100%
• Nanoparticle 100%
• Neoplasm 40%
• Nanomedicine 40%
• Tolerability 20%
• Paclitaxel 20%
• Cancer Drug Development 20%
• Enhanced Permeability and Retention Effect 20%